Cytomegalovirus Infection and Pre-Eclampsia

1. Espinoza J, Uckele JE, Starr RA, et al. Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 2010;203(1):17.e1-8.10.1016/j.ajog.2009.10.891Search in Google Scholar

2. ACOG Committee on Obstetric Practice. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33. January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 2002;77(1):67-7510.1016/S0029-7844(01)01747-1Search in Google Scholar

3. Rasmussen LG, Lykke JA, Staff AC. Angiogenic biomarkers in pregnancy: defining maternal and fetal health. Acta Obstet Gynecol Scand 2015;94(8):820-32.10.1111/aogs.1262925753566Search in Google Scholar

4. Staff AC, Dechend R, Redman CW. Review: Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypothese. Placenta 2013;34:S73-8.10.1016/j.placenta.2012.11.02223246096Search in Google Scholar

5. Staff AC, Johnsen GM, Dechend R, Redman CWG. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol 2014;101-102:120-26.10.1016/j.jri.2013.09.00124119981Search in Google Scholar

6. Redman CW, Sargent il, Staff AC. IFPA Senior award lecture: making sense of pre-eclampsia-Two placental causes of preeclampsia? Placenta 2014;35:S20-S25.10.1016/j.placenta.2013.12.00824477207Search in Google Scholar

7. Macey MG, Bevan S, Alam S et al. Platelet activation and endogenous thrombin potential in pre-eclampsia. Thromb Res 2010;125(3):e76-81.10.1016/j.thromres.2009.09.01319822350Search in Google Scholar

8. Conde-Agudelo A, Vilar J, Lindheimer M. Maternal infection and risk of preeclampsia: systemic review and metaanalysis. Am J Obstet Gynecol 2008;198(1):7-22.10.1016/j.ajog.2007.07.04018166297Search in Google Scholar

9. Xie F, Hu Y, Magee Laura A, et al. An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand 2010;89(9):1162-7.10.3109/00016349.2010.49944920804342Search in Google Scholar

10. Warner JA, Zwezdaryk KJ, Day B, Sullivan DE, Pridjian G, Morris CA. Human cytomegalovirus infection inhibits CXCL12-mediated migration and invasion of human extravillous cytotrophoblasts. Virol J. 2012;1(9):255.10.1186/1743-422X-9-255354597023116176Search in Google Scholar

11. Fisher SJ. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol 2015; 213(4Suppl):S115-22.10.1016/j.ajog.2015.08.042459274226428489Search in Google Scholar

12. Xie F, von Dadelszen P, Nadeau J. CMV infection, TLR-2 and-4 expression, and cytokine profiles in early-onset preeclampsia with HELLP syndrome. Am J Reprod Immunol 2014;71(4):379-86.10.1111/aji.12199399925424612145Search in Google Scholar

13. Xie F, Turvey SE, Williams MA, Mor G, von Dadelszen P. Toll-like receptor signaling and pre-eclampsia. Am J Reprod Immunol 2010;63(1):7-16.10.1111/j.1600-0897.2009.00745.x20059464Search in Google Scholar

14. Cunningham GF, Leveno KJ, Bloom SL, et al. Chapter 40: Hypertensive disorders in Williams Obstetrics 24rd Edition, McGrawHill Med Ed. USA. 2014:728-79.Search in Google Scholar

15. Xie F, Hu Y, Speert DP, et al. Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertens Pregnancy 2010;29(4):390-8.10.3109/1064195090324265920818954Search in Google Scholar

16. Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J 2008;12(2):223-42.10.1007/s10995-007-0224-117577649Search in Google Scholar

17. Gibson CS, Goldwater PN, MacLennan AH, et al. South Australian Cerebral Palsy Research Group. Fetal exposure to herpesviruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG 2008;115(4):492-500.10.1111/j.1471-0528.2007.01653.x716181418271886Search in Google Scholar

18. Cunningham GF, Leveno KJ, Bloom SL, et al. Chapter 64: Infectious diseases. Cytomegalovirus in Williams Obstetrics 24rd Edition, McGrawHill Med Ed. USA. 2014:1245-48.Search in Google Scholar

19. Boppana SB, Rivera LB, Fowler Kbet al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344(18):1366-7110.1056/NEJM20010503344180411333993Search in Google Scholar

20. Norwitz ER, Funai EF. Expectant management of severe preeclampsia remote from term: hope for the best, but expect the worst. Am J Obstet Gynecol 2008;199(3):209-12.10.1016/j.ajog.2008.06.08418771969Search in Google Scholar

21. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 2008;325:397-415.10.1007/978-3-540-77349-8_22269925918637518Search in Google Scholar

22. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovscular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974.10.1136/bmj.39335.385301.BE207204217975258Search in Google Scholar

23. Xie F, Hu F, Turvey SE et al. Toll-like receptors 2 and 4 and cryopyrin inflammasome in normal pregnancy and pre-eclampsia. BJOG 2010;117(1):99-108.10.1111/j.1471-0528.2009.02428.x20002372Search in Google Scholar

24. Strand KM, Odland ML, Iversen AC, et al. Cytomegalovirus antibody status at 17-18 weeks of gestation and pre-eclampsia: a case-control study of pregnant women in Norway. BJOG 2012;119(11):1316-23.10.1111/j.1471-0528.2012.03420.x22804776Search in Google Scholar